• Skip to content
  • skip to navigation
AstraZeneca logo AstraZeneca logo
AstraZeneca logo AstraZeneca logo
  • What science can do
    • What science can do
    • LabTalk blog
    • Our technology
    • Drug modalities
    • Artificial Intelligence
  • Our science
    • Our science
    • Pipeline
    • Publications
    • Cambridge
    • Gothenburg
    • Gaithersburg
  • Our therapy areas
    • All therapy areas
    • Oncology
    • Cardiovascular, Renal and Metabolism
    • Respiratory & Immunology
    • Other disease areas
    • All medicines
  • Our company
    • Our company
    • Our strategy
    • Our people
    • Leadership team
  • Careers
    • Careers
    • Global careers site
  • Investors
    • Investor Relations (Global) UK flag
    • Investor Relations (Sweden) Swedish flag
    • Stock Exchange announcements
    • Results and presentations
    • Annual Reports
    • Governance
    • Shareholder information
    • Dividend policy
    • Key facts
    • FAQs
    • Debt Investors
    • ADR Programme
  • Media
    • Press Releases
    • Media centre
    • Articles
    • Image library
    • Broadcast videos
    • Archive
    • Media contacts
  • Sustainability
    • Sustainability
    • Access to healthcare
    • Environmental protection
    • Ethics and transparency
    • Resources
  • Partnering
    • Partnering with AstraZeneca
    • Our Partnering teams
    • Our areas of partnering interest
    • Why partner with AstraZeneca?
    • Secrets to successful partnering
    • Supplier Information
  • AstraZeneca Websites
  • Global site

Showcasing our latest scientific advancements in type-2 diabetes and cardiorenal complications at ADA 2020

Read more

Diabetes

Helping HCPs to move beyond treating HbA1C to preventingearly cardio-renal complications

COVID-19 Information Hub


Targeting progression of liver damage in NASH

Read full story

Cardiovascular disease


Publications

Our innovative science means a strong track-record of publication in peer-reviewed journals, contributing to the foundation of scientific advancement.

View our publications

We have

167

projects in our pipeline

View pipeline

Cryo-electron microscopy

Explore our technology

Our Gaithersburg site (US) is one of AstraZeneca's three global strategic science centres

Explore our three strategic science centres

Our science

At AstraZeneca, science is at the core of everything we do. But more than that, science is who we are.

Find out more
Corporate Press Release

AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit

13 June 2020
Corporate Press Release

Calquence showed long-term efficacy and tolerability for patients with chronic lymphocytic leukaemia in two trials

12 June 2020



AstraZeneca Websites

This website is intended for people seeking information on AstraZeneca's worldwide business. Our country sites can be located in the AZ Network.




Veeva ID: Z4-8411
Date of next review: August 2020

Resources

  • All resources
  • Open Innovation
  • Externally sponsored scientific research
  • Medical Information for HCPs
  • US prescription assistance programmes
  • Global clinical trials information
  • Medicines
  • Report a possible side effect
  • Pearl Therapeutics

Quick links

  • Media
  • Investor Relations
  • Partnering
  • Careers
  • Sustainability
  • Modern Slavery Statement
  • Supplier information
  • Social Media Community Guidelines

Social Media

  • LinkedIn
  • Twitter
  • YouTube
  • Instagram
  • Glassdoor
  • Facebook

utility links

  • Legal notice and Terms of Use
  • Privacy notice
  • Cookie policy
  • Site map
  • Contact us

© AstraZeneca 2020

You are now leaving AstraZeneca.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.

Cancel Continue
?

Important notice for users

You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.

I disagree I agree
?
?